Clinician talk – John Isaacs, Newcastle University
Patient story – Versus Arthritis
Vice-President Development and General Manager
Sharon Grimster has been an active member of the UK bioprocessing community for more than 30 years, and she feels fortunate that her career spans an amazing period in biopharmaceutical development from working in manufacturing at Celltech in the early days of large scale GMP bioprocessing, up to her current role working with ATMPs at ReNeuron. Sharon was the chair of the BIA MAC from 2003 to 2006, and worked with the BIA to implement the recommendations of the BIGT report which resulted in the formation of BioProcess UK, for which she was the first chair of the steering committee.
Prior to working at ReNeuron, Sharon held senior team roles at Celltech, Antisoma and F-star, and during her career has had responsibility for a range of development functions, including project management, CMC, , medical devices, business operations, regulatory affairs and quality.
Sharon qualified as a coach at the Henley Business School, and she is also a current member of a number of industry steering groups and committees including MMIP, MAC and ATCC industry advisory group.
Dr Kate Barclay is an Independent Consultant working across high impact Science and Technology industries with a passion for STEM education. As a Chartered Chemical Engineer and Fellow of the IChemE, she has spent over 20 years in the Bio-Pharmaceutical Industry as a Senior Leader in Global R&D leading technical and scientific project teams in clinical manufacture of parenteral, solid dose and inhaled dosage forms as well as developing novel device technologies. Since 2013 Kate has been instrumental in developing apprenticeships across the Science Industry, leading the Life Sciences and Industrial Sciences Trailblazer employer group in development of new apprenticeship standards. She pioneered apprenticeship implementation across the science industry and has won multiple national awards for quality of apprenticeship delivery. Kate has a passion for promoting opportunities for women in STEM, is an experienced vocational workplace assessor for apprenticeships and a Non-Executive Director of the Institute for Apprenticeships, assuring quality governance to apprenticeship and Technical Education reforms across England.
How technology innovation can potentially improve bioprocesses and achieve some of the objectives of Industry 4.0.
Dr Peter R. Levison
In order to address the challenges faced as we move forward with the adoption of Industry 4.0 we have developed several new technologies and product platforms that supplement the existing toolboxes and are potential enablers for process improvement and optimization in the design of end-to-end processes. These will be illustrated and demonstrate how it should be possible to develop process flows using the technology platforms best optimised for optimal productivity based on kg product produced per year per unit facility footprint.
Peptide-based biomaterials for 3D cell culture and bioprinting
Biogelx supply unique peptide-based biomaterials to researchers around the globe who are interested in 3D cell culture and bioprinting. The core technology of these functional materials was developed at the University of Strathclyde by Prof Rein Ulijn, and Biogelx continue to develop new products and applications around this knowledge base. The company remains in touch with its academic roots by supporting 6 ongoing PhD studentships and acting as a contributing partner in a multicenter H2020-funded project involving academic and industry groups.